Medical effects of Azilsartan in patients with hypertension not controlled by other ARBs

Medical effects of Azilsartan in patients with hypertension not controlled by other ARBs - MAZIC study

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010610

Enrollment

400

Registered

2013-05-01

Start date

2013-05-01

Completion date

Unknown

Last updated

2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertension

Interventions

Azilsartan

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria: 1) A history of allergy/hypersensitivity 2) Pregnant women 12) Not eligible for this study based on the decision's of a physician

Design outcomes

Primary

Measure	Time frame
hospital blood pressure	—

Secondary

Measure	Time frame
home BP(early morning, evening),ABPM, urine albumin, BNP, hs-CRP, urinary sodium excretion, Serum K, eGFR, HbA1c	—

Countries

Japan

Contacts

Public ContactKenshi Hirayama

Anjo Kosei Hospital department of cardiology

kenshi28sep@gmail.com0566-75-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 4, 2026